Cochlear Bulls Anticipate Implant Market-Share Gains -- Market Talk

Dow Jones
06/12

0650 GMT - Cochlear's bulls at Jefferies think the stock looks cheap given the market-share gains likely to follow the launch of its new hearing-implant system. They look past the short-term hit of downgraded profit expectations for the current fiscal year to highlight the potential benefits of the new system. They tell clients in a note that they had only expected two new products, so a system containing three is a positive. They say Cochlear's medium-term outlook is now stronger than previously assumed, with the new system's tech capability likely to resonate with surgeons. Jefferies lifts its target price 1.0% to A$3.11 and keeps a buy rating on the stock, which closed 0.7% higher at A$272.31. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 12, 2025 02:50 ET (06:50 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10